Eli Lilly and Company - Enterprise Value To Sales Ratio

Eli Lilly and Company's Fiscal Year is From January To December.

The item "Enterprise-Value-To-Sales-Ratio" stands at 11.17 as of 09/30/2025, the lowest value since 06/30/2023.

As of the end of Eli Lilly and Company's third quarter, the item "Enterprise Value To Sales Ratio" stands at 11.17. This represents a decrease of -16.04 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -41.81 percent compared to the value the year prior.
The 1 year change in percent is -41.81.
The 3 year change in percent is 11.56.

The Serie's long term average value is 13.98. It's latest available value, on 09/30/2025, is 20.08 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is +26.98%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is -45.99%.